A Double-Blind Trial of Metoprolol in Acute Myocardial Infarction: Effects on Ventricular Tachyarrhythmias

New England Journal of Medicine

Volumn 308, Issue 11, 1983, Pages 614-618

  Ryden L ^a   Ariniego, R ^a   Arnman, K ^a   Herlitz, J ^a   Hjalmarson, A ^a   Holmberg, S ^a   Reyes, C ^a   Smedgard P ^a   Svedberg, K ^a   Vedin, A ^a   Waagstein, F ^a   Waldenstrom A ^a   Wilhelmsson, C ^a   Wedel, H ^a   Yamamoto, M ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

LIDOCAINE; METOPROLOL; PLACEBO;

CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COMPARISON; DRUG EFFICACY; DRUG THERAPY; HEART; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PREVENTION; THERAPY;

EID: 0020672207     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198303173081102     Document Type: Article

References (32)

1. Vedin JA, Wilhelmsson CE, Elmfeldt D, Tibblin G, Wilhelmsen L, Werkö L. Sudden death: identification of high risk groups. Am Heart J. 1973; 86: 124–32.
2. Kotler MN, Tabatznik B, Mower MM, Tominaga S. Prognostic significance of ventricular ectopic beats with respect to sudden death in the last postin-farction period. Circulation. 1973; 47: 959–66.
3. Vismara LA, Amsterdam EA, Mason DT. Relation of ventricular arrhythmias in the late hospital phase of acute myocardial infarction to sudden death after hospital discharge. Am J Med. 1975; 59: 6–12.
4. Ruberman W, Weinblatt E, Goldberg JD, Frank CW, Shapiro S. Ventricular premature beats and mortality after myocardial infarction. N Engl J Med. 1977; 297: 750–7.
5. Moss AJ, Davis HT, DeCamilla J, Bayer LW. Ventricular ectopic beats and their relation to sudden and nonsudden cardiac death after myocardial infarction. Circulation. 1979; 60: 998–1003.
6. Collaborative Group. Phenytoin after recovery from myocardial infarction: controlled trial in 568 patients. Lancet. 1971; 2: 1055–7.
7. Pouleur H, Chaudron JM, Reyns P. Effects of disopyramide and aprindine on arrhythmias after acute myocardial infarction. Eur J Cardiol. 1977; 5: 397–404.
8. Danilo P Jr. Aprindine. Am Heart J. 1979; 97: 119–24.
9. Rydén L, Amman K, Conradson T-B, Hofvendahl S, Mortensen O, Smedgård P. Prophylaxis of ventricular arrhythmias with intravenous and oral tocainide in patients with and recovering from acute myocardial infarction. Am Heart J. 1980; 100: 1006–12.
10. Campbell RWF, Achuff SC, Pottage A, Murray A, Prescott LF, Julian DG. Mexiletine in the prophylaxis of ventricular arrhythmias during acute myocardial infarction. J Cardiovasc Pharmacol. 1979; 1: 43–52.
11. Snow PJD. Effect of propranolol in myocardial infarction. Lancet. 1965; 2: 551–3.
12. The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 1981; 304: 801–7.
13. Hjalmarson A., Elmfeldt D, Herlitz J, et al. Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomised trial. Lancet. 1981; 2: 823–7.
14. β-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA. 1982; 247: 1707–14.
15. Herlitz J, Hjalmarson A., Holmberg S, et al. Limitation of infarct size in acute myocardial infarction with metoprolol. Am J Cardiol. 1982: 49:1004.
16. Ydse B, Ryden L, Ståhl LIS. Tillförlitligheten av ett automatiserat system för analys av bandspelarekg. Acta Soc Med Suec Hyg. 1981; 90: 94.
17. Lawrie DM, Higgins MR, Godman MJ, Oliver MF, Julian DG, Donald KW. Ventricular fibrillation complicating acute myocardial infarction. Lancet. 1968; 2: 523–8.
18. Mogensen L. Ventricular tachyarrhythmias and lignocaine prophylaxis in acute myocardial infarction: a clinical and therapeutic study. Acta Med Scand [Suppl]. 1970; 513: 1–80.
19. Dhurandhar RW, MacMillan RL, Brown KWG. Primary ventricular fibrillation complicating acute myocardial infarction. Am J Cardiol. 1971; 27: 347–51.
20. Lie KI, Wellens HJJ, Downar E, Durrer D. Observations on patients with primary ventricular fibrillation complicating acute myocardial infarction. Circulation. 1975; 52: 755–9.
21. El-Scherif N, Myerburg RJ, Scherlag BJ, et al. Electrocardiographic antecedents of primary ventricular fibrillation: value of the R-on-T phenomenon in myocardial infarction. Br Heart J. 1976; 38: 415–22.
22. Bigger JT Jr, Weld FM. Analysis of prognostic significance of ventricular arrhythmias after myocardial infarction: shortcomings of Lown grading system. Br Heart J. 1981; 45: 717–24.
23. Federman J, Whitford JA, Anderson ST, Pitt A. The effect of a selective beta adrenergic blocking agent on ventricular arrhythmias in the first year following myocardial infarction. Aust NZ J Med. 1980; 10: 289–94.
24. Körst HA, Brandes J-W, Lembcke HJ, Littmann KP. Die Behandlung ventrikulärer Extrasystolen mit Atenolol: eine Doppelblindstudie mit 68 Fällen. Z Kardiol. 1981; 70: 419–24.
25. Gradman AH, Winkle RA, Fitzgerald JW, et al. Suppression of premature ventricular contractions by acebutolol. Circulation. 1977; 55: 785–91.
26. Ahumada GG, Karlsberg RP, Jaffe AS, Ambos HD, Sobel BE, Roberts R. Reduction of early ventricular arrhythmia by acebutolol in patients with acute myocardial infarction. Br Heart J. 1979; 41: 654–9
27. Dahlström U, Berglund U, Karlsson E. Established beta-adrenergic receptor blocking therapy and acute myocardial infarction: a clinical study of risks and benefits. Acta Med Scand. 1980; 207: 167–71.
28. Lie KI, Wellens HJ, van Capelle FJ, Durrer D. Lidocaine in the prevention of primary ventricular fibrillation: a double-blind, randomized study of 212 consecutive patients. N Engl J Med. 1974; 291: 1324–6.
29. Resnekov L. The intermediate coronary care unit: a stage in continued coronary care. Br Heart J. 1977; 39: 357–62.
30. Kan MI, Hamilton JT, Manning GW. Protective effect of beta adrenoceptor blockade in experimental coronary occlusion in conscious dogs. Am J Cardiol. 1972; 30: 832–7.
31. Opie LH, Nathan D, Lubbe WF. Biochemical aspects of arrhythmogenesis and ventricular fibrillation. Am J Cardiol. 1979; 43: 131–48.
32. Opie LH, Lubbe WF. Catecholamine-mediated arrhythmias in acute myocardial infarction: experimental evidence and role of beta-adrenoceptor blockade. S Afr Med J. 1979; 56: 871–80.